More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...
SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
Oncodetect uses whole exome sequencing to analyze circulating tumor DNA, providing quantitative insights into disease status for informed treatment decisions. The test offers a "Detected" or "Not ...
"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...
Medical Device Network on MSN
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody related autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results